Market Exclusive

Analyst Downgrades – Celgene (NASDAQ:CELG) Stock Gets Downgraded By Credit Suisse Group from Buy to Hold

Analyst Ratings For Celgene (NASDAQ:CELG)

Today, Celgene (NASDAQ:CELG) stock was downgraded by Credit Suisse Group from Buy to Hold with a price target of $90.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Celgene (NASDAQ:CELG)
Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 77.84%.

Recent Trading Activity for Celgene (NASDAQ:CELG)
Shares of Celgene closed the previous trading session at 88.07 down -7.71 8.05% with 87.11000061035156 shares trading hands.

Exit mobile version